The Clinical Cure Project of Chronic Hepatitis B in China

NCT04035837 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

30000

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: pegylated interferon-alfa

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University